This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is MS Stock Worth Buying Post Q1 Earnings Amid M&A Activity Concerns?
by Ronit Masi
Is Morgan Stanley stock a lucrative bet after the solid first-quarter 2025 results, given the delayed IB rebound amid tariff concerns? Let's find out.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Morgan Stanley (MS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Morgan Stanley (MS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Company News for Apr 14, 2025
by Zacks Equity Research
Companies In The Article Are:JPM,MS,WFC,BK
JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview
by Zacks Equity Research
JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp have been highlighted in this Earnings Preview article.
Are Tariff Worries Affecting the Earnings Outlook?
by Sheraz Mian
There are many valid reasons for the market to remain focused on tariffs since so much is happening in the broader economy. But how are they affecting the earnings outlook for the coming periods?
Morgan Stanley Tops Q1 Earnings Estimates on Solid IB & NII, Stock Up
by Zacks Equity Research
MS' first-quarter 2025 earnings beat estimates courtesy of strong IB and NII. Higher provisions and expenses, however, play spoilsports.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Morgan Stanley (MS) have what it takes? Let's find out.
PPI for March Comes in Negative
by Zacks Equity Research
PPI for March Comes in Negative.
U.S./China Trade at +125% Standoff, PPI Slides, Big Banks Report Q1
by Mark Vickery
Trade between the U.S. and China -- worth $582 billion in 2024 -- has apparently ground to a halt.
Morgan Stanley (MS) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Morgan Stanley (MS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Morgan Stanley (MS) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Morgan Stanley (MS) delivered earnings and revenue surprises of 16.59% and 6.62%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Morgan Stanley (MS) Soars 11.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Morgan Stanley (MS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
What Should Be Your Stance on Bank ETFs Before Earnings Releases?
by Sanghamitra Saha
The health of the banking sector looks moderately sound, apart from some pain points. If the economy can manage the occasional tariff-driven threat, we should see smooth sailing in bank ETFs.
Citigroup (C) Soars 9.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Citigroup (C) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Here's How to Play Goldman Stock Ahead of Its Q1 Earnings Release
by Riya Anand
GS is set to report first-quarter 2025 earnings. We assess the factors influencing its performance and how investors should play this stock now.
Morgan Stanley (MS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Morgan Stanley (MS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights JPMorgan, Wells Fargo, Morgan Stanley, Delta Air Lines and Constellation Brands
by Zacks Equity Research
JPMorgan, Wells Fargo, Morgan Stanley, Delta Air Lines and Constellation Brands are included in this Analyst Blog.
Morgan Stanley (MS) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the latest trading session, Morgan Stanley (MS) closed at $100.92, marking a +1.09% move from the previous day.
The First Q1 Earnings Land: Global Week Ahead
by John Blank
Global investors have yearned for clarity over President Trump's tariffs. But now they have it, and don't much like what they see.
Should You Buy MS Shares Ahead of Q1 Earnings Amid Tariff Turmoil?
by Swayta Shah
As Trump's tariffs wreak havoc across the globe, let's decipher whether Morgan Stanley stock is worth buying ahead of Q1 earnings.
JPMorgan, Wells Fargo, Bank of America and Morgan Stanely are part of Zacks Earnings Preview
by Zacks Equity Research
JPMorgan, Wells Fargo, Bank of America and Morgan Stanely are part of Zacks Earnings Preview.
A Closer Look at Bank Stocks & Tariff Worries
by Sheraz Mian
We all know that the banking business isn't subject to tariffs. But as cyclical operators, their business is heavily exposed to trends in the broader economy, which in turn is seen as weighed down by the ongoing tariffs uncertainty.
US Bank Stocks Tumble as Sweeping Tariff Stokes Recession Fears
by Riya Anand
Shares of C, BAC, MS, GS and WFC took a heavy hit on Thursday's trading session after Trump announced sweeping tariffs, raising recession risks.